Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO25102 | Goniobranchus kuniei | Species | Chromodorididae | Eukaryota | UNPD* | |||
NPO1626 | Primnoa reseda | Species | Primnoidae | Eukaryota | UNPD* | |||
NPO12712 | Cereus bridgesii | Species | Sagartiidae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT235 | Individual Protein | C-C chemokine receptor type 4 | Homo sapiens | Inhibition | = | 18.62 | % | 20099827 |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 89125.1 | nM | PubChem BioAssay data set |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 12589.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 28183.8 | nM | PubChem BioAssay data set | ||
NPT4770 | Individual Protein | High-affinity choline transporter | Homo sapiens | IC50 | 13665.23 | nM | PubChem BioAssay data set | |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 1995.3 | nM | PubChem BioAssay data set | |
NPT1043 | Individual Protein | Glycoprotein hormones alpha chain | Homo sapiens | Potency | 1000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 18356.4 | nM | PubChem BioAssay data set | ||
NPT920 | Individual Protein | Alpha-synuclein | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT535 | Individual Protein | Parathyroid hormone receptor | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT105 | Individual Protein | Muscleblind-like protein 1 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC168259 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9593 | High Similarity | NPC32463 |
0.9496 | High Similarity | NPC52247 |
0.9496 | High Similarity | NPC187868 |
0.9412 | High Similarity | NPC302107 |
0.9344 | High Similarity | NPC244495 |
0.9344 | High Similarity | NPC93219 |
0.9339 | High Similarity | NPC315807 |
0.9328 | High Similarity | NPC247553 |
0.9291 | High Similarity | NPC131950 |
0.9286 | High Similarity | NPC307289 |
0.9206 | High Similarity | NPC250727 |
0.9194 | High Similarity | NPC243688 |
0.9134 | High Similarity | NPC281558 |
0.9077 | High Similarity | NPC38874 |
0.9077 | High Similarity | NPC474886 |
0.9 | High Similarity | NPC96705 |
0.9 | High Similarity | NPC152306 |
0.9 | High Similarity | NPC74821 |
0.8984 | High Similarity | NPC194277 |
0.8968 | High Similarity | NPC185066 |
0.8926 | High Similarity | NPC298796 |
0.8926 | High Similarity | NPC295259 |
0.8915 | High Similarity | NPC163557 |
0.8898 | High Similarity | NPC474289 |
0.8889 | High Similarity | NPC258567 |
0.8889 | High Similarity | NPC121740 |
0.8889 | High Similarity | NPC224774 |
0.8872 | High Similarity | NPC170812 |
0.8872 | High Similarity | NPC183642 |
0.8872 | High Similarity | NPC310370 |
0.8871 | High Similarity | NPC472518 |
0.8862 | High Similarity | NPC190454 |
0.8862 | High Similarity | NPC97432 |
0.8852 | High Similarity | NPC258979 |
0.8852 | High Similarity | NPC8283 |
0.8852 | High Similarity | NPC93398 |
0.8843 | High Similarity | NPC265547 |
0.8819 | High Similarity | NPC469453 |
0.8819 | High Similarity | NPC219923 |
0.88 | High Similarity | NPC140521 |
0.88 | High Similarity | NPC111347 |
0.88 | High Similarity | NPC73413 |
0.88 | High Similarity | NPC201667 |
0.8797 | High Similarity | NPC71903 |
0.879 | High Similarity | NPC96286 |
0.879 | High Similarity | NPC257188 |
0.879 | High Similarity | NPC13007 |
0.879 | High Similarity | NPC248429 |
0.878 | High Similarity | NPC319378 |
0.878 | High Similarity | NPC163200 |
0.877 | High Similarity | NPC281356 |
0.8769 | High Similarity | NPC31849 |
0.8741 | High Similarity | NPC91492 |
0.8741 | High Similarity | NPC7439 |
0.8741 | High Similarity | NPC256555 |
0.8741 | High Similarity | NPC34245 |
0.8741 | High Similarity | NPC110067 |
0.873 | High Similarity | NPC249836 |
0.8722 | High Similarity | NPC144512 |
0.8722 | High Similarity | NPC137262 |
0.8722 | High Similarity | NPC47040 |
0.8722 | High Similarity | NPC35501 |
0.8722 | High Similarity | NPC278600 |
0.8722 | High Similarity | NPC37428 |
0.872 | High Similarity | NPC76465 |
0.872 | High Similarity | NPC273772 |
0.872 | High Similarity | NPC154176 |
0.872 | High Similarity | NPC109675 |
0.872 | High Similarity | NPC290605 |
0.872 | High Similarity | NPC173350 |
0.872 | High Similarity | NPC38761 |
0.8712 | High Similarity | NPC223616 |
0.871 | High Similarity | NPC54972 |
0.871 | High Similarity | NPC193364 |
0.871 | High Similarity | NPC144418 |
0.8702 | High Similarity | NPC326600 |
0.8702 | High Similarity | NPC204353 |
0.8702 | High Similarity | NPC50896 |
0.8692 | High Similarity | NPC113006 |
0.8692 | High Similarity | NPC19157 |
0.8682 | High Similarity | NPC113098 |
0.8678 | High Similarity | NPC128633 |
0.8676 | High Similarity | NPC471824 |
0.8661 | High Similarity | NPC471826 |
0.8651 | High Similarity | NPC78446 |
0.8651 | High Similarity | NPC27671 |
0.8651 | High Similarity | NPC291899 |
0.8651 | High Similarity | NPC159132 |
0.8651 | High Similarity | NPC229113 |
0.8647 | High Similarity | NPC184861 |
0.8647 | High Similarity | NPC294456 |
0.8647 | High Similarity | NPC212124 |
0.8647 | High Similarity | NPC225106 |
0.8647 | High Similarity | NPC281014 |
0.8647 | High Similarity | NPC131198 |
0.8644 | High Similarity | NPC141068 |
0.864 | High Similarity | NPC100099 |
0.864 | High Similarity | NPC36016 |
0.8629 | High Similarity | NPC235190 |
0.8629 | High Similarity | NPC180006 |
0.8626 | High Similarity | NPC277021 |
0.8615 | High Similarity | NPC267336 |
0.8615 | High Similarity | NPC37009 |
0.8615 | High Similarity | NPC272650 |
0.8615 | High Similarity | NPC73738 |
0.8615 | High Similarity | NPC29734 |
0.8615 | High Similarity | NPC66430 |
0.8613 | High Similarity | NPC226722 |
0.8613 | High Similarity | NPC101255 |
0.8613 | High Similarity | NPC43716 |
0.8613 | High Similarity | NPC475719 |
0.8613 | High Similarity | NPC295696 |
0.8613 | High Similarity | NPC71739 |
0.8605 | High Similarity | NPC168710 |
0.8593 | High Similarity | NPC254994 |
0.8583 | High Similarity | NPC471827 |
0.8583 | High Similarity | NPC471828 |
0.8583 | High Similarity | NPC103420 |
0.8583 | High Similarity | NPC278552 |
0.8583 | High Similarity | NPC232692 |
0.8583 | High Similarity | NPC102540 |
0.8583 | High Similarity | NPC207179 |
0.8583 | High Similarity | NPC17809 |
0.8583 | High Similarity | NPC285040 |
0.8583 | High Similarity | NPC188022 |
0.8583 | High Similarity | NPC202594 |
0.8583 | High Similarity | NPC167571 |
0.8582 | High Similarity | NPC332594 |
0.8582 | High Similarity | NPC148738 |
0.8582 | High Similarity | NPC73078 |
0.8582 | High Similarity | NPC319870 |
0.8582 | High Similarity | NPC221046 |
0.8582 | High Similarity | NPC279573 |
0.8582 | High Similarity | NPC327612 |
0.8571 | High Similarity | NPC188380 |
0.8571 | High Similarity | NPC224543 |
0.8571 | High Similarity | NPC78746 |
0.8571 | High Similarity | NPC26954 |
0.8571 | High Similarity | NPC38099 |
0.8561 | High Similarity | NPC253574 |
0.8561 | High Similarity | NPC274121 |
0.8561 | High Similarity | NPC213216 |
0.8561 | High Similarity | NPC50898 |
0.8561 | High Similarity | NPC92830 |
0.8561 | High Similarity | NPC78540 |
0.8561 | High Similarity | NPC98179 |
0.8561 | High Similarity | NPC62366 |
0.855 | High Similarity | NPC137949 |
0.855 | High Similarity | NPC469956 |
0.854 | High Similarity | NPC36181 |
0.854 | High Similarity | NPC36732 |
0.8527 | High Similarity | NPC472519 |
0.8527 | High Similarity | NPC199204 |
0.8525 | High Similarity | NPC85292 |
0.8525 | High Similarity | NPC229147 |
0.8525 | High Similarity | NPC54507 |
0.8516 | High Similarity | NPC50315 |
0.8516 | High Similarity | NPC230479 |
0.8516 | High Similarity | NPC276212 |
0.8516 | High Similarity | NPC283049 |
0.8516 | High Similarity | NPC471215 |
0.8516 | High Similarity | NPC234109 |
0.8516 | High Similarity | NPC188327 |
0.8516 | High Similarity | NPC262573 |
0.8516 | High Similarity | NPC26879 |
0.8507 | High Similarity | NPC232246 |
0.8507 | High Similarity | NPC153818 |
0.8504 | High Similarity | NPC197351 |
0.8504 | High Similarity | NPC246648 |
0.8504 | High Similarity | NPC106914 |
0.8504 | High Similarity | NPC134195 |
0.8504 | High Similarity | NPC86502 |
0.8496 | Intermediate Similarity | NPC248872 |
0.8496 | Intermediate Similarity | NPC234865 |
0.8496 | Intermediate Similarity | NPC33986 |
0.8496 | Intermediate Similarity | NPC172262 |
0.8489 | Intermediate Similarity | NPC154217 |
0.8485 | Intermediate Similarity | NPC142563 |
0.8485 | Intermediate Similarity | NPC1220 |
0.8485 | Intermediate Similarity | NPC469449 |
0.8485 | Intermediate Similarity | NPC2363 |
0.8485 | Intermediate Similarity | NPC469955 |
0.8485 | Intermediate Similarity | NPC185777 |
0.8485 | Intermediate Similarity | NPC83535 |
0.8485 | Intermediate Similarity | NPC469952 |
0.8485 | Intermediate Similarity | NPC205797 |
0.8485 | Intermediate Similarity | NPC141822 |
0.8485 | Intermediate Similarity | NPC291551 |
0.8485 | Intermediate Similarity | NPC472524 |
0.8485 | Intermediate Similarity | NPC241165 |
0.8478 | Intermediate Similarity | NPC87609 |
0.8478 | Intermediate Similarity | NPC196459 |
0.8478 | Intermediate Similarity | NPC470296 |
0.8478 | Intermediate Similarity | NPC94794 |
0.8478 | Intermediate Similarity | NPC188632 |
0.8478 | Intermediate Similarity | NPC112791 |
0.8478 | Intermediate Similarity | NPC86069 |
0.8473 | Intermediate Similarity | NPC137264 |
0.8462 | Intermediate Similarity | NPC197425 |
0.8462 | Intermediate Similarity | NPC134360 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC168259 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9496 | High Similarity | NPD422 | Phase 1 |
0.9 | High Similarity | NPD1548 | Phase 1 |
0.871 | High Similarity | NPD1610 | Phase 2 |
0.8667 | High Similarity | NPD3750 | Approved |
0.8651 | High Similarity | NPD3225 | Approved |
0.8485 | Intermediate Similarity | NPD5124 | Phase 1 |
0.8485 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.8438 | Intermediate Similarity | NPD2797 | Approved |
0.8397 | Intermediate Similarity | NPD1296 | Phase 2 |
0.8397 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.8385 | Intermediate Similarity | NPD4908 | Phase 1 |
0.8385 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.8385 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.8309 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.8309 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.8308 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.8296 | Intermediate Similarity | NPD3748 | Approved |
0.8258 | Intermediate Similarity | NPD3268 | Approved |
0.8258 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.8248 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8197 | Intermediate Similarity | NPD5535 | Approved |
0.8188 | Intermediate Similarity | NPD1652 | Phase 2 |
0.8162 | Intermediate Similarity | NPD1510 | Phase 2 |
0.8154 | Intermediate Similarity | NPD1203 | Approved |
0.8134 | Intermediate Similarity | NPD1613 | Approved |
0.8134 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.8102 | Intermediate Similarity | NPD1551 | Phase 2 |
0.8067 | Intermediate Similarity | NPD9697 | Approved |
0.8028 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.8015 | Intermediate Similarity | NPD3267 | Approved |
0.8015 | Intermediate Similarity | NPD3266 | Approved |
0.8 | Intermediate Similarity | NPD1240 | Approved |
0.7958 | Intermediate Similarity | NPD1511 | Approved |
0.791 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7902 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7899 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7883 | Intermediate Similarity | NPD1607 | Approved |
0.7872 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7863 | Intermediate Similarity | NPD4749 | Approved |
0.7862 | Intermediate Similarity | NPD1653 | Approved |
0.7857 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7847 | Intermediate Similarity | NPD1512 | Approved |
0.7846 | Intermediate Similarity | NPD1535 | Discovery |
0.7823 | Intermediate Similarity | NPD7411 | Suspended |
0.781 | Intermediate Similarity | NPD4340 | Discontinued |
0.7801 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.78 | Intermediate Similarity | NPD3749 | Approved |
0.7786 | Intermediate Similarity | NPD9717 | Approved |
0.7786 | Intermediate Similarity | NPD1481 | Phase 2 |
0.777 | Intermediate Similarity | NPD7033 | Discontinued |
0.7733 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7714 | Intermediate Similarity | NPD2796 | Approved |
0.7708 | Intermediate Similarity | NPD6799 | Approved |
0.7682 | Intermediate Similarity | NPD7075 | Discontinued |
0.7676 | Intermediate Similarity | NPD1243 | Approved |
0.7671 | Intermediate Similarity | NPD5403 | Approved |
0.7667 | Intermediate Similarity | NPD940 | Approved |
0.7667 | Intermediate Similarity | NPD4288 | Approved |
0.7667 | Intermediate Similarity | NPD846 | Approved |
0.7655 | Intermediate Similarity | NPD5401 | Approved |
0.7652 | Intermediate Similarity | NPD1608 | Approved |
0.7651 | Intermediate Similarity | NPD6801 | Discontinued |
0.763 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7616 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7609 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7609 | Intermediate Similarity | NPD4060 | Phase 1 |
0.76 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.76 | Intermediate Similarity | NPD7819 | Suspended |
0.76 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7591 | Intermediate Similarity | NPD2313 | Discontinued |
0.7591 | Intermediate Similarity | NPD6798 | Discontinued |
0.7586 | Intermediate Similarity | NPD7213 | Phase 3 |
0.7586 | Intermediate Similarity | NPD7212 | Phase 2 |
0.7584 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7566 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7561 | Intermediate Similarity | NPD968 | Approved |
0.7538 | Intermediate Similarity | NPD1894 | Discontinued |
0.7534 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7533 | Intermediate Similarity | NPD1934 | Approved |
0.7518 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7517 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7517 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7517 | Intermediate Similarity | NPD6599 | Discontinued |
0.75 | Intermediate Similarity | NPD3496 | Discontinued |
0.75 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD2801 | Approved |
0.7465 | Intermediate Similarity | NPD6100 | Approved |
0.7465 | Intermediate Similarity | NPD2935 | Discontinued |
0.7465 | Intermediate Similarity | NPD6099 | Approved |
0.7464 | Intermediate Similarity | NPD3764 | Approved |
0.7464 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.745 | Intermediate Similarity | NPD8158 | Clinical (unspecified phase) |
0.7445 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7444 | Intermediate Similarity | NPD1091 | Approved |
0.7444 | Intermediate Similarity | NPD1611 | Approved |
0.7438 | Intermediate Similarity | NPD1242 | Phase 1 |
0.7434 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7434 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7432 | Intermediate Similarity | NPD920 | Approved |
0.7424 | Intermediate Similarity | NPD4626 | Approved |
0.7424 | Intermediate Similarity | NPD17 | Approved |
0.7415 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7394 | Intermediate Similarity | NPD2799 | Discontinued |
0.7391 | Intermediate Similarity | NPD7095 | Approved |
0.7389 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7379 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7368 | Intermediate Similarity | NPD3847 | Discontinued |
0.736 | Intermediate Similarity | NPD1358 | Approved |
0.732 | Intermediate Similarity | NPD5402 | Approved |
0.7308 | Intermediate Similarity | NPD6671 | Approved |
0.7305 | Intermediate Similarity | NPD6355 | Discontinued |
0.7297 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7293 | Intermediate Similarity | NPD1778 | Approved |
0.7286 | Intermediate Similarity | NPD6233 | Phase 2 |
0.728 | Intermediate Similarity | NPD3134 | Approved |
0.7279 | Intermediate Similarity | NPD6667 | Approved |
0.7279 | Intermediate Similarity | NPD6666 | Approved |
0.7273 | Intermediate Similarity | NPD9545 | Approved |
0.725 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7222 | Intermediate Similarity | NPD290 | Approved |
0.7219 | Intermediate Similarity | NPD3226 | Approved |
0.7218 | Intermediate Similarity | NPD5691 | Approved |
0.7214 | Intermediate Similarity | NPD411 | Approved |
0.7206 | Intermediate Similarity | NPD6582 | Phase 2 |
0.7206 | Intermediate Similarity | NPD6583 | Phase 3 |
0.7203 | Intermediate Similarity | NPD4978 | Clinical (unspecified phase) |
0.7194 | Intermediate Similarity | NPD2614 | Approved |
0.7192 | Intermediate Similarity | NPD2800 | Approved |
0.7188 | Intermediate Similarity | NPD3818 | Discontinued |
0.7185 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7183 | Intermediate Similarity | NPD447 | Suspended |
0.7178 | Intermediate Similarity | NPD7549 | Discontinued |
0.7165 | Intermediate Similarity | NPD2684 | Approved |
0.7161 | Intermediate Similarity | NPD3882 | Suspended |
0.7154 | Intermediate Similarity | NPD1241 | Discontinued |
0.7152 | Intermediate Similarity | NPD6232 | Discontinued |
0.7143 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7133 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.7122 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7121 | Intermediate Similarity | NPD9493 | Approved |
0.7115 | Intermediate Similarity | NPD6971 | Discontinued |
0.7114 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7113 | Intermediate Similarity | NPD4140 | Approved |
0.7107 | Intermediate Similarity | NPD2859 | Approved |
0.7107 | Intermediate Similarity | NPD2860 | Approved |
0.7089 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7083 | Intermediate Similarity | NPD7097 | Phase 1 |
0.708 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.7077 | Intermediate Similarity | NPD7843 | Approved |
0.7073 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.707 | Intermediate Similarity | NPD919 | Approved |
0.7067 | Intermediate Similarity | NPD2533 | Approved |
0.7067 | Intermediate Similarity | NPD2532 | Approved |
0.7067 | Intermediate Similarity | NPD2534 | Approved |
0.7063 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7063 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7063 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7063 | Intermediate Similarity | NPD230 | Phase 1 |
0.7063 | Intermediate Similarity | NPD1933 | Approved |
0.7063 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7055 | Intermediate Similarity | NPD2344 | Approved |
0.7055 | Intermediate Similarity | NPD2346 | Discontinued |
0.7055 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7055 | Intermediate Similarity | NPD5953 | Discontinued |
0.705 | Intermediate Similarity | NPD1019 | Discontinued |
0.705 | Intermediate Similarity | NPD2798 | Approved |
0.705 | Intermediate Similarity | NPD6917 | Clinical (unspecified phase) |
0.705 | Intermediate Similarity | NPD6584 | Phase 3 |
0.7044 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7042 | Intermediate Similarity | NPD4062 | Phase 3 |
0.7037 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7037 | Intermediate Similarity | NPD7054 | Approved |
0.7037 | Intermediate Similarity | NPD6516 | Phase 2 |
0.7037 | Intermediate Similarity | NPD5846 | Approved |
0.7029 | Intermediate Similarity | NPD8651 | Approved |
0.7029 | Intermediate Similarity | NPD1283 | Approved |
0.7027 | Intermediate Similarity | NPD3892 | Phase 2 |
0.7025 | Intermediate Similarity | NPD2934 | Approved |
0.7025 | Intermediate Similarity | NPD2933 | Approved |
0.7021 | Intermediate Similarity | NPD5163 | Phase 2 |
0.7019 | Intermediate Similarity | NPD7473 | Discontinued |
0.7012 | Intermediate Similarity | NPD6559 | Discontinued |
0.7 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD7837 | Clinical (unspecified phase) |
0.6994 | Remote Similarity | NPD7074 | Phase 3 |
0.6994 | Remote Similarity | NPD7472 | Approved |
0.6993 | Remote Similarity | NPD943 | Approved |
0.6993 | Remote Similarity | NPD5808 | Clinical (unspecified phase) |
0.6986 | Remote Similarity | NPD1537 | Approved |
0.6986 | Remote Similarity | NPD4477 | Approved |
0.6986 | Remote Similarity | NPD1519 | Approved |
0.6986 | Remote Similarity | NPD1538 | Phase 1 |
0.6986 | Remote Similarity | NPD4476 | Approved |
0.6981 | Remote Similarity | NPD6959 | Discontinued |
0.6978 | Remote Similarity | NPD1164 | Approved |
0.6978 | Remote Similarity | NPD987 | Approved |
0.6977 | Remote Similarity | NPD4750 | Phase 3 |
0.6977 | Remote Similarity | NPD5451 | Approved |
0.6974 | Remote Similarity | NPD6980 | Clinical (unspecified phase) |
PubChem CID   | 5398649 |
ChEMBL   | CHEMBL600635 |
ZINC   |
Molecular Weight:   | 254.06 |
ALogP:   | -0.8462 |
MLogP:   | 2.67 |
XLogP:   | 3.799 |
# Rotatable Bonds:   | 3 |
Polar Surface Area:   | 66.76 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 2 |
# Rings:   | 3 |
# Heavy Atoms:   | 19 |